Literature DB >> 29615149

miR-455 Functions as a Tumor Suppressor Through Targeting GATA6 in Colorectal Cancer.

Hua Yunqi1, Yin Fangrui2, Yang Yongyan1, Jin Yunjian1, Zhang Wenhui1, Cao Kun1, Li Min1, Liu Xianfeng1, Ba Caixia1.   

Abstract

Emerging evidence indicates that microRNAs (miRNAs) are often aberrantly expressed in human cancers. Meanwhile, the importance of miRNAs in regulating multiple cellular biological processes has been appreciated. The aim of this study was to investigate the significance of miR-455 and identify its possible mechanism in regulating colorectal cancer (CRC) progression. We found that the expression of miR-455 was sharply reduced in CRC tissues and cell lines. Importantly, the low expression of miR-455 was associated with poor overall survival of CRC patients. Overexpression of miR-455 in CRC cell lines significantly inhibited cell proliferation and migration in vitro. Moreover, GATA-binding protein 6 (GATA6), whose expression can be inversely regulated by miR-455 in CRC cell lines, was validated as a direct target of miR-455. Overall, our results revealed that miR-455 functions as a tumor suppressor, and its downregulation may contribute to CRC progression. Our study may provide a novel therapeutic target for CRC in the future.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29615149     DOI: 10.3727/096504018X15220579006875

Source DB:  PubMed          Journal:  Oncol Res        ISSN: 0965-0407            Impact factor:   5.574


  8 in total

1.  miR-196b-5p-mediated downregulation of TSPAN12 and GATA6 promotes tumor progression in non-small cell lung cancer.

Authors:  Guang Liang; Wei Meng; Xiangjie Huang; Wangyu Zhu; Changtian Yin; Canwei Wang; Matteo Fassan; Yun Yu; Masahisa Kudo; Sisi Xiao; Chengguang Zhao; Peng Zou; Yumin Wang; Xiaokun Li; Carlo M Croce; Ri Cui
Journal:  Proc Natl Acad Sci U S A       Date:  2020-02-10       Impact factor: 11.205

2.  Silencing of DLEU2 suppresses pancreatic cancer cell proliferation and invasion by upregulating microRNA-455.

Authors:  Baoli Xu; Xufei Gong; Li Zi; Guang Li; Shuxiao Dong; Xinrui Chen; Yutao Li
Journal:  Cancer Sci       Date:  2019-03-25       Impact factor: 6.716

3.  Influence and mechanism of miR-99a suppressing development of colorectal cancer (CRC) with diabetes mellitus (DM).

Authors:  Peixuan Zhu; Jiahao Liu; Meijuan Lu; Gongfa Wu; Xutao Lin; Longmei Cai; Xiaona Zhang
Journal:  Onco Targets Ther       Date:  2019-11-27       Impact factor: 4.147

4.  miR-205-3p promotes proliferation and reduces apoptosis of breast cancer MCF-7 cells and is associated with poor prognosis of breast cancer patients.

Authors:  Changhong Qiu; Fei Huang; Qing Zhang; Wei Chen; Huiting Zhang
Journal:  J Clin Lab Anal       Date:  2019-10-02       Impact factor: 2.352

5.  lncRNA TUG1 Facilitates Colorectal Cancer Stem Cell Characteristics and Chemoresistance by Enhancing GATA6 Protein Stability.

Authors:  Junfeng Sun; Hangyuan Zhou; Xingqi Bao; Yue Wu; Haowei Jia; Hongchao Zhao; Guanghui Liu
Journal:  Stem Cells Int       Date:  2021-11-23       Impact factor: 5.443

Review 6.  Present Status, Challenges, and Prospects of Dihydromyricetin in the Battle against Cancer.

Authors:  Jiajun Wu; Zuowei Xiao; Hongfang Li; Neng Zhu; Jia Gu; Wenmao Wang; Chao Liu; Wei Wang; Li Qin
Journal:  Cancers (Basel)       Date:  2022-07-18       Impact factor: 6.575

7.  miR-455 Inhibits the Viability and Invasion by Targeting RAB18 in Hepatocellular Carcinoma.

Authors:  Chenghong Wang; Guicai Zhu; Miaolin Yu; Xiufang Mi; Honghua Qu
Journal:  J Oncol       Date:  2021-05-27       Impact factor: 4.375

Review 8.  Epigenetic Regulation by lncRNAs: An Overview Focused on UCA1 in Colorectal Cancer.

Authors:  Bernadette Neve; Nicolas Jonckheere; Audrey Vincent; Isabelle Van Seuningen
Journal:  Cancers (Basel)       Date:  2018-11-14       Impact factor: 6.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.